Compare VTSI & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTSI | CING |
|---|---|---|
| Founded | 1993 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.5M | 40.5M |
| IPO Year | N/A | 2021 |
| Metric | VTSI | CING |
|---|---|---|
| Price | $4.97 | $4.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $7.00 | ★ $31.33 |
| AVG Volume (30 Days) | 61.1K | ★ 261.4K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | ★ $24,934,267.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.39 | N/A |
| P/E Ratio | $346.40 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.57 | $3.20 |
| 52 Week High | $7.47 | $6.74 |
| Indicator | VTSI | CING |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 52.79 |
| Support Level | $4.54 | $4.83 |
| Resistance Level | $5.07 | $6.74 |
| Average True Range (ATR) | 0.25 | 0.57 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 77.75 | 25.32 |
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.